Aberrations in KIT expression and signaling, including over-expression or reduced/absent expression, have been characterized in several tumors, such as gastrointestinal stromal tumors, breast cancer, and thyroid carcinoma [12–15], but the role of KIT in human neoplasia is not fully cleared understood. This evidence concerns the gene KIT and breast cancer.